Immune Response of A Novel ATR-AP205-001 Conjugate Anti-hypertensive Vaccine

We developed a virus-like particle (VLP)-based therapeutic vaccine against angiotensin II receptor type 1, ATR-AP205-001, which could significantly reduce the blood pressure and protect target organs of hypertensive animals. In this study, we focused on the immunological effect and safety of the VLP...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiajun, Deng, Yihuan, Chen, Xiao, Zhou, Yanzhao, Zhang, Hongrong, Wu, Hailang, Yang, Shijun, Chen, Fen, Zhou, Zihua, Wang, Min, Qiu, Zhihua, Liao, Yuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626684/
https://www.ncbi.nlm.nih.gov/pubmed/28974760
http://dx.doi.org/10.1038/s41598-017-12996-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626684/
https://www.ncbi.nlm.nih.gov/pubmed/28974760
http://dx.doi.org/10.1038/s41598-017-12996-y

Ejemplares similares